BD enrolls first patient in registry study for PAD treatment device

BD has successfully enrolled its first patient in a groundbreaking registry study aimed at evaluating a new treatment device for peripheral artery disease (PAD). This is significant as PAD affects millions and can lead to serious health complications. By advancing research in this area, BD is not only contributing to better treatment options but also enhancing patient outcomes, which is crucial for public health.